Validity and reliability of the EQ-5D for cancer patients in Korea

Supportive Care in Cancer

Volumn 20, Issue 12, 2012, Pages 3155-3160

  Kim, Seon Ha ^a   Hwang, Jung Sung ^a   Kim, Tae Won ^b   Hong, Yong Sang ^b   Jo, Min Woo ^a  

^a University of Ulsan College of Medicine   (South Korea)

^b Asan Medical Center   (South Korea)

Author keywords

Colorectal cancer; EORTC QLQ C30; EQ 5D; Reliability; SF 36; Validity

Indexed keywords

ADULT; AGED; ARTICLE; CANCER PATIENT; COLORECTAL CANCER; CONVERGENT VALIDITY; DIVERGENT VALIDITY; EQ-5D HEALTH QUESTIONNAIRE; EUROPEAN ORGANIZATION FOR RESEARCH AND TREATMENT OF CANCER QUALITY OF LIFE QUESTIONNAIRE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; SHORT FORM 36; SOUTH KOREA; TEST RETEST RELIABILITY; VALIDITY;

ADULT; AGED; AGED, 80 AND OVER; COLORECTAL NEOPLASMS; FEMALE; HUMANS; MALE; MIDDLE AGED; PSYCHOMETRICS; QUALITY OF LIFE; QUESTIONNAIRES; REPRODUCIBILITY OF RESULTS; REPUBLIC OF KOREA;

EID: 84868475323     PISSN: 09414355     EISSN: 14337339     Source Type: Journal    
DOI: 10.1007/s00520-012-1457-0     Document Type: Article

References (29)

1. The Korea Central Cancer Registry, National Cancer Center (2010) Annual report of cancer statistics in Korea in 2008. Ministry of Health and Welfaree
2. Nayfield SG, Ganz PA, Moinpour CM et al (1992) Report from a National Cancer Institute (USA) workshop on quality of life assessment in cancer clinical trials. Qual Life Res 1(3):203-210
3. Torrance GW (1986) Measurement of health state utilities for economic appraisal. J Health Econ 5(1):1-30
4. Cost-effectiveness in health and medicine. In Gold MR, Siegal JE, Russell LB, et al (Eds.) (1996) Oxford University Press. New Yorkk
5. Räsänen P, Roine E, Sintonen H et al (2006) Use of qualityadjusted life years for the estimation of effectiveness of health care: a systematic literature review. Int J Technol Assess Health Care 22(2):235-41
6. Aaronson NK, Ahmedzai S, Bergman B et al (1993) The European Organization for Research and Treatment of Cancer QLQ C-30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 85:365-76
7. Rowen D, Brazier J, Young T et al (2011) Deriving a preferencebased measure for cancer using the EORTC QLQ-C30. Value Health 14(5):721-31
8. (1996) Quality of life and pharmacoeconomics in clinical trials. 2nd edn. In Spilker, B. (Ed.) Lippincott-Raven. Philadelphiaa
9. Health Insurance Review and Assessment service (2006) Guidelines for economic evaluation of pharmaceuticalss
10. Kim MH, Cho YS, Uhm WS et al (2005) Cross-cultural adaptation and validation of the Korean version of the EQ-5D in patients with rheumatic diseases. Qual Life Res 14(5):1401-1406
11. Kim SH, Kim HJ, Lee SI, et al. Comparing the psychometric properties of the EQ-5D-3L and EQ-5D-5L in cancer patients in Korea. Qual Life Res. 2011 Sep 23. DOI 10.1007/s11136-011-0018-1
12. Brooks R, Rabin RE, de Charro F (2003) The measurement and valuation of health status using EQ-5D: a European perspective. Kluwer Academic Publishers, Dordrechtt
13. Yun YH, Park YS, Lee ES et al (2004) Validation of the Korean version of the EORTC QLQ-C30. Qual Life Res 13(4):863-868
14. Ware JE Jr, Kosinski MB, Bjorner JB et al (2007) User's manual for the SF-36v2® health survey, 2nd edn. Quality Metric Incorporated, Lincolnn
15. Han CW, Lee EJ, Iwaya T et al (2004) Development of the Korean version of short-form 36-item health survey: health related QOL of healthy elderly people and elderly patients in Korea. Tohoku J Exp Med 203(3):189-194
16. McHorney CA, Ware JE Jr, Raczek AE (1993) The MOS 36-item short-form health survey (SF-36): II. Psychometric and clinical tests of validity in measuring physical and mental health constructs. Med Care 31(3):247-263
17. Brazier JE, Harper R, Jones NM et al (1992) Validating the SF-36 health survey questionnaire: new outcome measure for primary care. BMJ 305(6846):160-164
18. McHorney CA, Ware JE Jr, Lu JF et al (1994) The MOS 36-item short-form health survey (SF-36): III. Tests of data quality, scaling assumptions, and reliability across diverse patient groups. Med Care 32(1):40-66
19. Lee YK, Nam HS, Chuang LH et al (2009) South Korean time trade-off values for EQ-5D health states: modeling with observed values for 101 health states. Value Health 12(8):1187-1193
20. Brazier J, Roberts J, Deverill M (2002) The estimation of a preference-based measure of health from the SF-36. J Health Econ 21(2):271-292
21. Brazier J, Jones N, Kind P (1993) Testing the validity of the Euroqol and comparing it with the SF-36 health survey questionnaire. Qual Life Res 2(3):169-180
22. Kontodimopoulos N, Pappa E, Niakas D et al (2008) Validity of the EuroQoL (EQ-5D) instrument in a Greek general population. Value Health 11(7):1162-1169
23. Chang TJ, Tarn YH, Hsieh CL et al (2007) Taiwanese version of the EQ-5D: validation in a representative sample of the Taiwanese population. J Formos Med Assoc 106(12):1023-1031
24. Johnson JA, Coons SJ (1998) Comparison of the EQ-5D and SF-12 in an adult US sample. Qual Life Res 7(2):155-166
25. Johnson JA, Pickard AS (2000) Comparison of the EQ-5D and SF-12 health surveys in a general population survey in Alberta, Canada. Med Care 38(1):115-121
26. Lang HC, Chuang L, Shun SC et al (2010) Validation of EQ-5D in patients with cervical cancer in Taiwan. Support Care Cancer 18 (10):1279-1286
27. Fleiss JL (1981) Statistical methods for rates and proportions, 2nd edn. Wiley, New York
28. Hripcsak G, Heitjan DF (2002) Measuring agreement in medical informatics reliability studies. J Biomed Inform 35(2):99-110
29. Hurst NP, Kind P, Ruta D et al (1997) Measuring health-related quality of life in rheumatoid arthritis: validity, responsiveness and reliability of EuroQol (EQ-5D). Br J Rheumatol 36(5):551-559